November 26 and 27, 2009 - Closed
December 1, 2009 - Closed at 2:30 PM
December 24 and 25, 2009 - Closed
www.LanDomainiums.com
October 20, 2009 — Most patients with vaccine allergy may be safely vaccinated, according to a practice parameter published in the October issue of the Annals of Allergy, Asthma & Immunology. However, the new guidelines also recommend that patients with suspected allergy to vaccines or vaccine components be evaluated by an allergist or immunologist vs simply avoiding future immunizations, which could leave patients at higher risk for infectious disease.
The new recommendations were issued by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology.
"Local, injection site reactions and constitutional symptoms, especially fever, are common after vaccinations and do not contraindicate future doses," chief editor John M. Kelso, MD, from the Division of Allergy, Asthma & Immunology at Scripps Clinic in San Diego, California, said in a news release.
Summary Statements in the Parameter
Specific summary statements in the parameter include the following:
"The 2 key points of the practice parameter are that (1) patients with suspected allergy to vaccines or vaccine components should be evaluated by an allergist/immunologist and (2) most patients with suspected allergy to vaccines can receive vaccination safely," the guidelines authors conclude.
Ann Allergy Asthma Immunol. 2009;103:S1-14.
Daniel J. DeNoon
October 19, 2009 — Beware fake "Tamiflu" sold over the Internet, the FDA warns.
The FDA recently bought five different products advertised online as "Tamiflu" or as treatments for the 2009 H1N1 swine flu.
Some of the pills contained only talc and acetaminophen. Some had various amounts of oseltamivir, the active ingredient in Tamiflu. None was the real thing; all are illegal in the U.S.
Moreover, all the fake "Tamiflu" products arrived by mail too late to do any good -- even if they had been the real thing.
"Medicines purchased from web sites operating outside the law put consumers at increased risk due to a higher potential that the products will be counterfeit, impure, contaminated, or have too little or too much of the active ingredient," FDA Commissioner Margaret Hamburg, MD, says in a news release.
There are only two drugs approved by the FDA for treatment of H1N1 swine flu: Tamiflu and Relenza. Both drugs are available only by prescription.
SOURCES:
www.LANDOMAINIUMS.COM
NEW YORK (Reuters Health) Oct 09 - The most effective way to manage frequent wheezing in preschool children is regular treatment with nebulized glucocorticoids, according to a report in the October issue of Allergy.
The authors of the report also suggest that as-needed use of a bronchodilator and glucocorticoid combination, which is commonly practiced, may be an alternative.
Dr. Leonardo M. Fabbri, of the University of Modena and Reggio Emilia, Italy, and colleagues conducted a trial in which 276 children ages 1 to 4 years with frequent wheeze were randomized to nebulized treatment with one of three regimens for 12 weeks: 400 mcg beclomethasone twice daily plus 2500 mcg salbutamol as needed; placebo plus a combination of 800 mcg beclomethasone/1600 mcg salbutamol as needed, or placebo plus 2500 mcg salbutamol as needed.
The primary outcome measure -- percentage of symptom-free days -- was significantly higher with daily beclomethasone (69.6%) compared with as-needed salbutamol (61.0%; p = 0.034).
Regular treatment with nebulized beclomethasone also improved several secondary outcomes, including nocturnal wakening and exacerbations.
There was no difference in percentage of symptom-free days between children with or without risk factors for asthma.
Allergy 2009;64:1463-1471.
Get Domains and Web-Hosting
Please call 859-371-3797 and ask for the research coordinator.